survivin/midkine-targeting LSP vaccine (Vaxeal)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesurvivin/midkine-targeting LSP vaccine (Vaxeal)
Drug Alias Namesurvivin/midkine vaccine (Vaxeal)survivin/midkine-targeting long synthetic peptide vaccine (Vaxeal)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionMidkine inhibitorsBaculoviral IAP repeat-containing protein 5 inhibitors
TargetsBaculoviral IAP repeat-containing protein 5Midkine
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVaxeal Holding SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVaxeal Holding SA
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A